The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
Open accessAbstract
Background: Many adults eligible for statin therapy for cardiovascular disease prevention are untreated. Our objective was to investigate patient‐reported reasons for statin underutilization, including noninitiation, refusal, and discontinuation. Methods and Results: This study included the 5693 adults recommended for statin therapy in the PALM (Patient and Provider Assessment of Lipid Management) registry. Patient surveys evaluated statin experience, reasons for declining or discontinuing statins, and beliefs about statins and cardiovascular disease risk. Overall, 1511 of 5693 adults (26.5%) were not on treatment. Of those not on a statin, 894 (59.2%) reported never being offered a statin, 153 (10.1%) declined a statin, and 464 (30.7%) had discontinued therapy. Women (relative risk: 1.22), black adults (relative risk: 1.48), and those without insurance (relative risk: 1.38) were most likely to report never being offered a statin. Fear of side effects and perceived side effects were the most common reasons cited for declining or discontinuing a statin. Compared with statin users, those who declined or discontinued statins were less likely to believe statins are safe (70.4% of current users vs. 36.9% of those who declined and 37.4% of those who discontinued) or effective (86.3%, 67.4%, and 69.1%, respectively). Willingness to take a statin was high; 67.7% of those never offered and 59.7% of patients who discontinued a statin would consider initiating or retrying a statin. Conclusions: More than half of patients eligible for statin therapy but not on treatment reported never being offered one by their doctor. Concern about side effects was the leading reason for statin refusal or discontinuation. Many patients were willing to reconsider statin therapy if offered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In a registry that studied reasons why eligible patients were not taking a statin, 59% reported never being offered treatment, 10% declined a statin, and 31% discontinued therapy.18”
From Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients (2023) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Self-citationA Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,920
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,781
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Self-citationAdherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077
Persistence of Use of Lipid-Lowering Medications
Avorn, J., Monette, J., Lacour, A. S., Bohn, R. L., Monane, M., Mogun, H., & LeLorier, J. (1998) · JAMA · doi:10.1001/jama.279.18.1458 · Cited by 635
Application of New Cholesterol Guidelines to a Population-Based Sample
Pencina, M. J., Navar‐Boggan, A. M., D’Agostino, R. B., Williams, K., Neely, B., Sniderman, A. D., & Peterson, E. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315665 · Cited by 612
Self-citationNissen, S. E., Stroes, E., Dent-Acosta, R. E., Rosenson, R. S., Lehman, S. J., Sattar, N., Preiss, D., Bruckert, E., Ceška, R., Lepor, N., et al. (2016) · JAMA · doi:10.1001/jama.2016.3608 · Cited by 522
Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials
Kashani, A., Phillips, C. O., Foody, J. M., Wang, Y., Mangalmurti, S., Ko, D. T., & Krumholz, H. M. (2006) · Circulation · doi:10.1161/circulationaha.106.624890 · Cited by 474
Cited by
Sorted by citations
Items 101–200 of 286
Sex differences in the perception of cardiovascular risk in familial hypercholesterolemia
Alshibani, B., Iatan, I., Guérin, A., Ruel, I. L., Cermakova, L., Ramanakumar, A. V., Pilote, L., Coutinho, T. A., Brunham, L. R., & Genest, J. J. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.10.007 · Cited by 10
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?
Surma, S., Sahebkar, A., & Banach, M. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01186-z · Cited by 10
Nonstatin therapy to reduce low-density lipoprotein cholesterol and improve cardiovascular outcomes
Singh, A., & Cho, L. S. (2024) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.91a.23058 · Cited by 12
Statin use and outcome risks according to predicted CVD risk in Korea: A retrospective cohort study
Jung, H. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245609 · Cited by 10
Statins and Cognitive Impairment
Iadecola, C., & Parikh, N. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.040 · Cited by 10
Tudor, K., Brooks, J., Howick, J., Fox, R., & Aveyard, P. (2022) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.007793 · Cited by 9
Inequities in atherosclerotic cardiovascular disease prevention
Gomez, S. E., Dudum, R., & Rodríguez, F. (2024) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.05.002 · Cited by 9
Examining the Impact of Polygenic Risk Information in Primary Care
Pacyna, J. E., Ennis, J. S., Kullo, I. J., & Sharp, R. R. (2023) · Journal of Primary Care & Community Health · doi:10.1177/21501319231151766 · Cited by 9
Chang, Y., Lin, H.-M., Chi, K., Lin, W.-Y., & Chou, T.-C. (2023) · PeerJ · doi:10.7717/peerj.15149 · Cited by 9
Karalis, D. G. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000896 · Cited by 9
Glarner, N., Puelacher, C., Gualandro, D. M., Buse, G. L., Hidvegi, R., Bolliger, D., Lampart, A., Burri‐Winkler, K., Pargger, M., Gerhard, H., et al. (2023) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001903 · Cited by 9
Brunette, C. A., Dong, O. M., Vassy, J. L., Danowski, M. E., Alexander, N. V. J., Antwi, A. A., & Christensen, K. D. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111123 · Cited by 9
Shen, M., Nargesi, A. A., Nasir, K., Bhatt, D. L., & Khera, R. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026075 · Cited by 9
Intensive Lipid-Lowering Therapy Following Acute Coronary Syndrome: The Earlier the Better
Pradhan, A. K., Sharma, P., Prajapathi, S., Aracri, M., Iellamo, F., & Perrone, M. A. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12080300 · Cited by 8
Khatib, R., Yeh, E. J., Glowacki, N., McGuiness, C. B., Xie, H., Wade, R. L., Kalich, B. A., Li, Y., Rifai, A., & Sawlani, N. N. (2023) · Clinical Epidemiology · doi:10.2147/clep.s400903 · Cited by 8
Boston, D., Larson, A. E., Sheppler, C. R., O'Connor, P. J., Sperl-Hillen, J., Hauschildt, J., & Gold, R. (2023) · Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2022.220391r2 · Cited by 7
Kayani, T., Ahmad, B., Chang, R., Qian, F., Sahinoz, M., Rehan, M., Giaimo, A., Spatz, E. S., & Hu, J. (2024) · Pharmacoepidemiology · doi:10.3390/pharma3010009 · Cited by 9
Krychtiuk, K. A., Andersson, T. L., Bodesheim, U., Butler, J., Curtis, L. H., Elkind, M. S. V., Hernandez, A. F., Hornik, C. P. V., Lyman, G. H., Khatri, P., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.01.004 · Cited by 8
The power of lipid registries for cardiovascular disease prevention
Nishikido, T., & Ray, K. K. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000783 · Cited by 8
Inglin, L., Lavikainen, P., Jalkanen, K., & Laatikainen, T. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-02077-6 · Cited by 7
Muck, M. A., Fischer, M., Hamerle, M., Strack, C., Holzhaeuer, M., Pfeffer, D., Hubauer, U., Maier, L. S., & Baessler, A. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00642-y · Cited by 7
Martinez, K. A., Montori, V. M., Rodríguez, F., Tereshchenko, L. G., Kovach, J. D., Boyer, C., Hurwitz, H., & Rothberg, M. B. (2025) · Medical Decision Making · doi:10.1177/0272989x251346508 · Cited by 6
Pharmacotherapy of cardiovascular diseases from herbs and pills to nucleic acids
Landmesser, U., Thum, T., Tokgözoğlu, L., Guzik, T. J., Cosentino, F., Hajjar, R. J., Gonçalves, A., Laguna-Fernández, A., Nioi, P., Prochaska, J. H., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf520 · Cited by 7
Alqasrawi, M. N., Al-Mahayri, Z. N., Khasawneh, L. Q., Albawa’neh, A. S., Dabaghie, L., Altoum, S. M., Hamza, D., Aburuz, S., Misra, V., Jamil, G., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1656520 · Cited by 6
Follow-Up Lipid Testing and Statin Initiation Among Young Adults in a U.S. Health Care System
Harrison, T. N., Zhang, Y., Choi, S. K., Pak, K. J., Zhou, H., Morrissette, K. L., Reynolds, K., Scott, R. D., & An, J. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.10.052 · Cited by 6
Emara, A., Gadelmawla, A. F., Awashra, A., Rifai, M. K., Elgendy, M. S., Diaa, A., Emara, M. R., Odat, R. M., Assaassa, A., & Shubietah, A. R. M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70316 · Cited by 6
Guilabert, L., Cárdenas‐Jaén, K., Vaillo-Rocamora, A., Ruiz-Rebollo, M. L., Bolado, F., Martinez-Moneo, E., Rivera-Irigoín, R., Martín‐Mateos, R., García-Rayado, G., López‐Serrano, A., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337154 · Cited by 6
Mefford, M. T., Zhou, M. M., Zhou, H. C., Derakhshan, H., Harrison, T. N., Zia, M., Kanter, M. H., Scott, R. D., Imley, T. M., Sanders, M. A., et al. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.04.009 · Cited by 6
Is there a role for earlier use of combination therapy?
Revankar, S., Park, J. K., Satish, P., & Agarwala, A. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100639 · Cited by 6
Singh, C., Valero, D. J., Nisar, J., Ramirez, J. I. T., Suchak, K. K., Isola, S., Hernandez, A. M. S., & Gordon, D. K. (2020) · Cureus · doi:10.7759/cureus.10965 · Cited by 6
Martin‐Latry, K., Latry, P., Bergès, C., Coste, P., Douard, H., Pucheu, Y., & Couffinhal, T. (2022) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2021.12.003 · Cited by 6
Byambasuren, O., Hattingh, L., Jones, M., Obucina, M., Craig, L., Clark, J. M., Hoffmann, T., Glasziou, P., & Cardona, M. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101529 · Cited by 6
Cupido, A. J., Hof, M. H. P., de Boer, L. M., Huijgen, R., Stroes, E. S. G., Kastelein, J. J. P., Hovingh, G. K., & Hutten, B. A. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.12.004 · Cited by 6
Non adherence to lipid-lowering therapy and strategies to improve adherence
Mehta, A. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.01.006 · Cited by 6
Nguyen, D. Q., Keshvani, N., Chandra, A., Alebna, P. L., Dixon, D. L., Shapiro, M. D., Michos, E. D., Sperling, L. S., Pandey, A., & Mehta, A. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100673 · Cited by 6
Advances in the management of statin myopathy
Gallo, A., Perregaux, J., & Bruckert, É. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000595 · Cited by 6
Groth, N. A., Stone, N. J., & Benziger, C. P. (2020) · Clinical Cardiology · doi:10.1002/clc.23521 · Cited by 6
Maitra, N. S., Mahtta, D., Navaneethan, S. D., Vaughan, E. M., Kochar, A., Gulati, M., Levine, G. N., Petersen, L. A., & Virani, S. S. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01694-5 · Cited by 7
Self-citationCórdoba‐Melo, B. D., Seni-Molina, S., Arango-Ibañez, J. P., Ayala, M. R., Méndez, J., Quintero-Yepes, V., Mejía-Cadavid, L. A., Cruz-Cuevas, J. D., Ordoñez, N. A., Buitrago, A. F., et al. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02657-9 · Cited by 6
Clinical practice guidelines: ensuring quality through international collaboration
Milojevic, M., Nikolić, A., Bakaeen, F. G., & Myers, P. O. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae237 · Cited by 5
Lee, J., Kang, M. W., Oh, J., Kim, M., Koh, J. H., Kang, E., Cho, J. M., Cho, S., Kim, S. G., Lee, S., et al. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf105 · Cited by 5
Patient-Reported Reasons for Not Using Primary Prevention Statin Therapy
DeWitt, C. M., Ponce, R. B., Bry, H., Wali, S., Sedlander, E., & Ladapo, J. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103337 · Cited by 5
Lim, H. M., Ng, C. J., Abdullah, A. B., & Dunn, A. G. (2023) · BMC Family Practice · doi:10.1186/s12875-023-02182-7 · Cited by 6
Feldman, D. I., Dudum, R., & Blumenthal, R. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-75055-8_8 · Cited by 5
Cramer, S. H. M., Cole, J. H., Budoff, M. J., Karlsberg, R. P., Gupta, H., Sullenberger, L. E., Rahban, H., Woods, K. M., Uzzilia, J. R., Purga, S. L., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf568 · Cited by 4
Ballantyne, C. M., Graham, T. E., Anglen, L. J. V., Iteld, B. J., Serota, H., Niu, X., McElligott, S. C., Hanna, K. E., & Varisco, T. J. (2025) · Cardiology and Therapy · doi:10.1007/s40119-025-00438-0 · Cited by 4
Taha, H., Kandil, H., Badran, H. M., Farag, N. M., Khamis, H., Nasr, G. M., Samy, M., Abdrabou, M., Abuelezz, M., & Shaker, M. M. (2024) · The Egyptian Heart Journal · doi:10.1186/s43044-024-00562-7 · Cited by 5
Statin Intolerance: An Overview for Clinicians
Surma, S., Lewek, J., Penson, P. E., & Banach, M. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_23 · Cited by 4
Carbonell-Soliva, Á., Nouni-García, R., López-Pineda, A., Cordero-Fort, A., Pérez-Jover, V., Quesada, J., Orozco-Beltrán, D., Nolasco, A., Castellano-Vázquez, J. M., Mira-Solves, J., et al. (2024) · BMC Primary Care · doi:10.1186/s12875-024-02286-8 · Cited by 6
Fanaroff, A. C., Huang, Q. E., Clark, K., Norton, L. A., Kellum, W. E., Eichelberger, D., Wood, J. C., Bricker, Z., Wood, A. G. D., Kemmer, G., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.04.013 · Cited by 4
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Bertolet, B. D., Cabral, K. P., Sullenberger, L. E., McAlister, J., Sandroni, T., & Patel, D. S. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00665-1 · Cited by 4
Legere, L., Chu, A., Rashid, M. K., Sivaswamy, A., O'Neill, T., Marquez, C., Baddeliyanage, R., Straus, S. E., & Udell, J. A. (2020) · Healthcare Quarterly · doi:10.12927/hcq.2020.26091 · Cited by 4
Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference
Edmonston, D. L., Roe, M. T., Block, G. A., Conway, P. T., Dember, L. M., DiBattiste, P. M., Greene, T., Hariri, A., Inker, L. A., Isakova, T., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.026 · Cited by 4
Troksa, K. A., Billups, S. J., Claus, L. W., Griend, J. P. V., & Saseen, J. J. (2020) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1222 · Cited by 4
Michos, E. D., & Ferdinand, K. C. (2022) · European Atherosclerosis Journal · doi:10.56095/eaj.v1i1.9 · Cited by 4
Factors associated with lipid lowering therapy in the multi-ethnic study of atherosclerosis
Cao, J., Guan, W., Nomura, S. J. O., Bhatia, H. S., Garg, P. K., & Tsai, M. Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02363-y · Cited by 3
Mefford, M. T., Zhou, H. C., Li, K., Zhou, M., Victores, A., Bash, L. D., An, J., Harrison, T. N., Scott, R. D., & Reynolds, K. (2025) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2025.07.011 · Cited by 3
Ba, Z., Zhao, S., Liu, M., Chen, G., Lian, X., Yu, F., Su, Y., Wang, Z., Yang, L., Wang, X., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-105597 · Cited by 3
Wakob, I., Wintsche, I., Frisch, A., Remane, Y., Laufs, U., Bertsche, T., & Schiek, S. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/6585271 · Cited by 2
Hay, E., Zhu, J., Thoma, F. W., Marroquin, O. C., Muluk, P., Countouris, M. E., Smith, A. J. C., Saeed, G. J., Rifai, M. A., Johnson, A. E., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101231 · Cited by 3
de Anta, L., Álvarez-Mon, M. Á., Pereira-Sánchez, V., Donat‐Vargas, C., Lara-Abelenda, F. J., Arrieta, M., Montero-Torres, M., Montero, C. G., Fraile‐Μartinez, O., Mora, F., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06111-5 · Cited by 3
Baneu, P., Prelipcean, A., Buda, V. O., Jianu, N., Tudor, A., Andor, M., Merlan, C., Romanescu, M., Suciu, M., Buda, S., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195970 · Cited by 4
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention
Kamanu, C., & Karalis, D. G. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01283-1 · Cited by 4
Prabhakar, A. P., Vedamurthy, D., & Kalra, D. K. (2025) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-025-00764-x · Cited by 3
Tunoa, J., Billups, S. J., Lowe, R. N., & Saseen, J. J. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.09.001 · Cited by 3
Worldwide statins prescription pattern: is it similar?
Amiri, M. (2020) · Biometrics & Biostatistics International Journal · doi:10.15406/bbij.2020.09.00320 · Cited by 3
The Role of Slco1B1 Genotyping in Lowering Cardiovascular Risk
Brunette, C. A., & Vassy, J. L. (2021) · Pharmacogenomics · doi:10.2217/pgs-2021-0075 · Cited by 3
Decicco, E., Peterson, E. D., Gupta, A., Gillard, K. K., Sarnes, E., & Návar, A. M. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100604 · Cited by 5
Self-citationSurvey of Personal Use of Statins by Prescribers
Stack, P. S., & Ogola, G. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.11.012 · Cited by 3
Gibson, C., Mount, R. R., Lee, J., & Backes, J. M. (2022) · Future Cardiology · doi:10.2217/fca-2022-0020 · Cited by 3
Adverse drug reactions in drug information databases: does presentation affect interpretation?
McConachie, S. M., Giuliano, C. A., Mohammad, I., & Kale-Pradhan, P. B. (2020) · Journal of the Medical Library Association JMLA · doi:10.5195/jmla.2020.748 · Cited by 3
Lowenstern, A. M., Li, S., Návar, A. M., Virani, S. S., Roger, V. L., Robinson, J. G., Goldberg, A. C., Kampman, W., Peterson, E. D., & Wang, T. Y. (2021) · Clinical Cardiology · doi:10.1002/clc.23625 · Cited by 2
Self-citationLife‐Saving Medications: The Urgent Need for Guideline Adherence and Patient Acceptance
Braun, L. T. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012348 · Cited by 3
Addressing Disparities in the Screening and Treatment of Dyslipidemia – A Call to Action
Converse, E., Watson, K., Ahmad, Z., Yang, E., Gianos, E., Sagheer, U., Virani, S. S., & Kalra, D. K. (2025) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-025-00769-6 · Cited by 2
Self-citationFrom LDL-C to lipoprotein(a) - those who fail to learn from history are doomed to repeat it
Sarraju, A., & Nissen, S. E. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101280 · Cited by 2
Singh, S., Raof, A. S. A., Lee-Boey, J. W. S., Zaini, H. S. M., Ooi, Y., & Lim, L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331571 · Cited by 2
Wright, A. P., McCoy, A. B., Garcia, K., Embí, P. J., Clair, W. K., Linton, M. F., & Wright, A. T. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09858-z · Cited by 2
Lan, N. S. R., Ryan, C. D., Rudén, A., Glasby, J. R. K., Nanayakkara, N., Elghattis, Y., Brazionis, L., Huang, M., Lum, S., Januszewski, A. S., et al. (2025) · Internal Medicine Journal · doi:10.1111/imj.70276 · Cited by 3
Audehm, R. G., Liew, D., Watts, G. F., Hespe, C. M., Rahman, M., Williamson, A. E., Sciascia, C., Santani, R., & Tonkin, A. M. (2025) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.07.012 · Cited by 2
Sung, K., Kang, D., Lee, J., Lee, S.-J., Cho, E. J., Jeong, J. A., Rhee, M., & Sung, D.-E. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03003-0 · Cited by 2
Corsetti, G., & Pasini, E. (2026) · Nutrients · doi:10.3390/nu18050722 · Cited by 3
Melaku, E. E., Tesfahun, E., Mulugeta, B., Ayidagnuhim, G. B., Hassen, E., & Tefera, A. S. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s435036 · Cited by 2
Jung, M., Lee, B., Lee, S., & Shin, J. (2024) · Annals of Pharmacotherapy · doi:10.1177/10600280241237781 · Cited by 2
Adherence to cardio-protective medications and cardiovascular disease in adults with type 1 diabetes
Lithovius, R., Mutter, S., Parente, E. B., Harjutsalo, V., & Groop, P. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111794 · Cited by 2
Sola, M., Mesenbring, E. C., Glorioso, T. J., Gualano, S. K., Atkinson, T. M., Duvernoy, C. S., & Waldo, S. W. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034312 · Cited by 2
Alexander, G. C., Curran, J. N., Victores, A., Mehta, H. B., Lin, S., Xiao, X., Michos, E. D., Ballreich, J. M., Bash, L. D., Exter, J., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09625-0 · Cited by 2
Lowenkamp, M. N., Nassereldine, H., Iams, A., Tzeng, E., & Reitz, K. M. (2025) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2025.09.054 · Cited by 2
Age and Age-old Disparities in Diabetes Care Persist
Ali, M. K., & Shah, M. K. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2392 · Cited by 2
2019 clinical trials in lipid lowering
Feldman, D. I., Pacor, J., Blumenthal, R. S., & Nasir, K. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000757 · Cited by 2
Ahmed, F., Gross, S., Hammad, S., Wilson, C., Nawas, G. T., & Zeini, B. (2021) · PubMed Central · Cited by 2
Arutyunov, G. P., Arutyunov, A. G., Ageev, F. T., & Фофанова, Т. В. (2022) · JMIR Cardio · doi:10.2196/37490 · Cited by 2
Slavin, S. D., Berman, A. N., Gaba, P., Hoshi, R. A., & Mittleman, M. A. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.11.007 · Cited by 3
The neuropsychology of statin intolerance
Robinson, J. G. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00502-3 · Cited by 2
Self-citationEditorial: statin use in patients with NAFLD—safety concerns, decreased awareness or both?
Mallet, M., & Pais, R. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16675 · Cited by 2
Yaputra, D. M., Wibowo, Y. I., Aditama, L., Brata, C., & Irawati, S. (2023) · MPI (Media Pharmaceutica Indonesiana) · doi:10.24123/mpi.v5i1.5494 · Cited by 1
Zheutlin, A. R., Jacobs, J. A., Derington, C. G., Chaitoff, A. M., Návar, A. M., & Bress, A. P. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.08.005 · Cited by 1
Smits, G., Bots, M. L., Hollander, M., & van Doorn, S. (2024) · BJGP Open · doi:10.3399/bjgpo.2024.0175 · Cited by 1
Wang, S., Qu, Y., Zhang, J., Xue, X., & Yang, Z. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11090268 · Cited by 1
Myerson, M. L., Warden, B. A., Saseen, J. J., & Paparodis, R. D. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.044134 · Cited by 1
van Egeraat, J. W. A., van Oortmerssen, J. A. E., van Lennep, J. E. R., Kavousi, M., Willemsen, R. T. A., Bonten, T. N., & Petrus, A. H. J. (2025) · Public Health · doi:10.1016/j.puhe.2025.106094 · Cited by 1
Metadata
- Authors
- Bradley, C. K., Wang, T. Y., Li, S., Robinson, J. G., Roger, V. L., Goldberg, A. C., Virani, S. S., Louie, M. J., Lee, L. V., Peterson, E. D., & Navar, A. M.
- Affiliations
- Duke University (US)
- University of Iowa (US)
- Mayo Clinic (US)
- Washington University in St. Louis (US)
- Baylor College of Medicine (US)
- Regeneron (United States) (US)
- Sanofi (United States) (US)
- Department of Medicine and Duke Clinical Research Institute Duke University School of Medicine Durham NC
- Corresponding author
- Bradley, Corey K.
- ORCID
- Venue
- Journal of the American Heart Association
- Published
- 2019-04-02
- Volume
- 8
- Issue
- 7
- Pages
- e011765-e011765
- ISSN
- 2047-9980 (ISSN-L)
- PMC
- PMC6509731
- OpenAlex
- W2923928888
- Cited by
- 286
- References
- 25
- Citations by year
- 2026: 34 · 2025: 41 · 2024: 56 · 2023: 43 · 2022: 30 · 2021: 41 · 2020: 28 · 2019: 13
- FWCI
- 26.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of the American Heart Association (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- eCommons - AKU (Aga Khan University) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K01HL133416)
- Duke Clinical Research Institute
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- statin therapy, statin discontinuation, fear of side effects, cardiovascular disease prevention, lipid control, health beliefs, racial and ethnic disparities, insurance status
- MeSH terms
- Patient Reported Outcome Measures, Adult, Aged, Attitude to Health, Black or African American, Cardiovascular Diseases, Fear, Female, Humans, Male, Middle Aged, Motivation, Practice Patterns, Physicians', Primary Prevention, Registries, Sex Factors, United States, Treatment Refusal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, White People, Atherosclerosis, Healthcare Disparities, Medication Adherence, Secondary Prevention, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
